Open
SectorHealthcare
63.45 -1.25
24h
Min
62.65
Max
64.05
Income | 3.9M 27M |
|---|---|
Sales | 4.8M 160M |
P/E Sector Avg | 23.263 37.461 |
EPS | 0.423 |
Dividend yield | 1.56 |
Profit margin | 16.767 |
Employees | 2,188 |
EBITDA | 4.2M 35M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +26.43% upside |
Dividend yield Sector Avg | 1.56% 2.33% |
|---|---|
Next Earnings | 6 lis 2025 |
Market Cap | 260M 3.1B |
|---|---|
Previous open | 64.7 |
Previous close | 63.45 |
By Acuity
50%
50%
154 / 373 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
By TipRanks
12 Months Forecast
Average 80.85 EUR 26.43%
High 90 EUR
Low 71.7 EUR
Based on 2 Wall Street analysts offering 12 month price targets forLaboratorios Farmaceuticos Rovi SA - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$